Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients.

Park, Sanghwa; Jeong, Jiseon; Woo, Yunna; Choi, Yeo Jin; Shin, Sooyoung

Park, Sanghwa; Jeong, Jiseon; Woo, Yunna; Choi, Yeo Jin; Shin, Sooyoung.

Affiliation

Park S; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Jeong J; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Woo Y; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Choi YJ; Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea. yeojin.choi@khu.ac.kr.
Shin S; College of Pharmacy, Ajou University, Suwon, Republic of Korea. syshin@ajou.ac.kr.

Sci Rep ; 13(1): 18462, 2023 10 27.

Article in En | MEDLINE | ID: mdl-37891260

Subject(s)

Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Metformin; Urinary Tract Infections; Humans; Male; Hypoglycemic Agents/adverse effects; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/chemically induced; Insulin/adverse effects; Cohort Studies; Metformin/adverse effects; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Urinary Tract Infections/complications; Retrospective Studies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract Infections / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Metformin Limits: Humans / Male Language: En Journal: Sci Rep Year: 2023 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google